Boothbay Fund Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1270 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1371 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1454 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1515 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1559 |
|
|
2023
Q2 | – | Sell |
-19,576
| Closed | -$704K | – | 1639 |
|
|
2023
Q1 | $704K | Sell |
19,576
-11,697
| -37% | -$421K | 0.01% | 955 |
|
|
2022
Q4 | $1.39M | Sell |
31,273
-5,845
| -16% | -$261K | 0.03% | 618 |
|
|
2022
Q3 | $1.04M | Sell |
37,118
-24,947
| -40% | -$701K | 0.03% | 741 |
|
|
2022
Q2 | $1.67M | Hold |
62,065
| – | – | 0.04% | 543 |
|
|
2022
Q1 | $2.11M | Buy |
62,065
+16,615
| +37% | +$566K | 0.05% | 471 |
|
|
2021
Q4 | $1.76M | Buy |
45,450
+19,041
| +72% | +$736K | 0.04% | 437 |
|
|
2021
Q3 | $1.43M | Sell |
26,409
-25,929
| -50% | -$1.4M | 0.04% | 476 |
|
|
2021
Q2 | $1.75M | Sell |
52,338
-21,861
| -29% | -$731K | 0.06% | 370 |
|
|
2021
Q1 | $1.53M | Sell |
74,199
-105,471
| -59% | -$2.17M | 0.06% | 334 |
|
|
2020
Q4 | $3.15M | Sell |
179,670
-6,447
| -3% | -$113K | 0.12% | 125 |
|
|
2020
Q3 | $2.76M | Sell |
186,117
-22,719
| -11% | -$337K | 0.17% | 123 |
|
|
2020
Q2 | $2.72M | Buy |
+208,836
| New | +$2.72M | 0.19% | 114 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 635 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 602 |
|